| SC 13G/A | 2022-02-23 | Iroquois Capital Management, LLC | Synthetic Biologics, Inc. | 908,195 | 0.9% | EDGAR |
| SC 13G/A | 2022-02-11 | RENAISSANCE TECHNOLOGIES LLC | Synthetic Biologics, Inc. | 20,600 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-04 | Hudson Bay Capital Management LP | Synthetic Biologics, Inc. | 2,608,696 | 1.9% | EDGAR |
| SC 13D/A | 2021-03-02 | Custodian Ventures LLC. | Synthetic Biologics, Inc. | 2,224,500 | 2.1% | EDGAR |
| SC 13G/A | 2021-02-22 | Iroquois Capital Management, LLC | Synthetic Biologics, Inc. | 1,130,195 | 5.4% | EDGAR |
| SC 13G/A | 2021-02-11 | Hudson Bay Capital Management LP | Synthetic Biologics, Inc. | 2,219,019 | 10.0% | EDGAR |
| SC 13G | 2021-02-10 | RENAISSANCE TECHNOLOGIES LLC | Synthetic Biologics, Inc. | 1,237,733 | 6.2% | EDGAR |
| SC 13D | 2021-01-06 | Custodian Ventures LLC. | Synthetic Biologics, Inc. | 1,964,500 | 9.9% | EDGAR |
| SC 13G/A | 2020-02-14 | Iroquois Capital Management, LLC | Synthetic Biologics, Inc. | 6,198 | 10.0% | EDGAR |
| SC 13G/A | 2020-01-21 | SABBY MANAGEMENT, LLC | Synthetic Biologics, Inc. | 838,641 | 5.0% | EDGAR |
| SC 13D/A | 2019-04-03 | KIRK RANDAL J | Synthetic Biologics, Inc. | 227,674 | 1.5% | EDGAR |
| SC 13G/A | 2019-02-14 | Iroquois Capital Management, LLC | Synthetic Biologics, Inc. | 320,516 | 10.0% | EDGAR |
| SC 13G/A | 2019-02-05 | Hudson Bay Capital Management LP | Synthetic Biologics, Inc. | 1,496,555 | 10.0% | EDGAR |
| SC 13G/A | 2019-01-17 | SABBY MANAGEMENT, LLC | Synthetic Biologics, Inc. | 1,117,459 | 7.6% | EDGAR |
| SC 13G | 2019-01-17 | SABBY MANAGEMENT, LLC | Synthetic Biologics, Inc. | 741,353 | 5.0% | EDGAR |
| SC 13G | 2018-10-18 | Iroquois Capital Management, LLC | Synthetic Biologics, Inc. | 311,934 | 10.0% | EDGAR |
| SC 13G/A | 2018-02-14 | Alyeska Investment Group, L.P. | Synthetic Biologics, Inc. | 5,000,000 | 3.9% | EDGAR |
| SC 13G/A | 2017-02-14 | Knoll Capital Management, LP | Synthetic Biologics, Inc. | 3,055,357 | 2.6% | EDGAR |
| SC 13G | 2017-02-14 | Alyeska Investment Group, L.P. | Synthetic Biologics, Inc. | 12,437,917 | 9.9% | EDGAR |
| SC 13G/A | 2017-01-12 | SABBY MANAGEMENT, LLC | Synthetic Biologics, Inc. | 5,820,952 | 5.0% | EDGAR |